Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

34.82
+0.41351.20%
Post-market: 34.820.00000.00%16:10 EDT
Volume:2K
Turnover:58.72K
Market Cap:13.93M
PE:- -
High:34.86
Open:34.76
Low:34.76
Close:34.41
52wk High:34.86
52wk Low:25.79
Shares:400.00K
Float Shares:400.00K
Volume Ratio:0.42
T/O Rate:0.42%
Dividend:0.08
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Bank of America Securities Raises Targets for Chinese CXO Firms on Strong Biotech Funding

Stock News
·
Aug 13

Perrigo Co. PLC Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 13

Zoetis Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 13

Biogen Files Form 3 Initial Beneficial Ownership Statement for Chief Legal Officer Michael Parini

Reuters
·
Aug 13

Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks

TIPRANKS
·
Aug 13

Moderna Inc. Stock Rises 5.1%, Outperforms Peers

Dow Jones
·
Aug 13

Merck & Co. Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 13

Merck Animal Health EVP Richard R. DeLuca Sells 45,320 Merck Shares Worth $5.97 Million

Reuters
·
Aug 13

Sector Update: Healthcare Stocks Advance Late Afternoon

MT Newswires Live
·
Aug 13

Merck Shares Rise After Daiwa Upgrade

MT Newswires Live
·
Aug 13

Merck Price Target Raised to $143.00/Share from $120.00 by Daiwa Capital

Dow Jones
·
Aug 12

Merck on Pace for Record High Close

Dow Jones
·
Aug 12

Legend Biotech Carvykti Growth, Profitability Outlook Remain Positive, RBC Says

MT Newswires Live
·
Aug 12

Madrigal Appoints J&J R&D Chief John Reed to Board

Reuters
·
Aug 12

Yiling Receives Notice for Clinical Trial Application of Its New Chemical Drug 'LB220-D08 Extended-Release Tablets'

Stock News
·
Aug 12

Zhejiang Jolly Pharmaceutical Receives Clinical Trial Approval for Lianlianhua Granules

Stock News
·
Aug 12

Jiangsu Hengrui Pharma Secures Clinical Trial Approval for Innovative Multi-Peptide Drug HRS-4729 Injection

Stock News
·
Aug 12

Chengdu Easton Biopharma Subsidiary Initiates Phase I/II Trial for Novel Lymphoma Drug, First Patient Dosed

Stock News
·
Aug 12

Haisco Pharmaceutical Group Receives Clinical Trial Approval for Novel Drug HSK60002 Tablet

Stock News
·
Aug 12

MacroGenics Rises on $10 Million Milestone Payment from Gilead

Reuters
·
Aug 12